USD 84.74
(-0.94%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 10.09 Billion USD | 15.77% |
2022 | 8.71 Billion USD | 5.14% |
2021 | 8.29 Billion USD | 21.34% |
2020 | 6.83 Billion USD | -8.99% |
2019 | 7.5 Billion USD | 4.96% |
2018 | 7.15 Billion USD | 5.32% |
2017 | 6.79 Billion USD | 2.97% |
2016 | 6.59 Billion USD | 1.2% |
2015 | 6.51 Billion USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 2.51 Billion USD | 2.12% |
2024 Q1 | 2.45 Billion USD | -0.79% |
2023 Q2 | 2.42 Billion USD | 2.98% |
2023 Q4 | 2.47 Billion USD | 6.42% |
2023 Q3 | 2.32 Billion USD | -3.84% |
2023 Q1 | 2.35 Billion USD | 8.34% |
2023 FY | 10.09 Billion USD | 15.77% |
2022 Q4 | 2.17 Billion USD | 1.45% |
2022 FY | 8.71 Billion USD | 5.14% |
2022 Q3 | 2.14 Billion USD | -3.47% |
2022 Q1 | 2.18 Billion USD | 1.86% |
2022 Q2 | 2.21 Billion USD | 1.28% |
2021 Q1 | 1.93 Billion USD | -0.52% |
2021 Q3 | 2.1 Billion USD | -0.38% |
2021 FY | 8.29 Billion USD | 21.34% |
2021 Q4 | 2.14 Billion USD | 2.24% |
2021 Q2 | 2.11 Billion USD | 9.33% |
2020 Q4 | 1.94 Billion USD | 5.55% |
2020 Q1 | 1.84 Billion USD | -3.76% |
2020 Q2 | 1.21 Billion USD | -34.06% |
2020 Q3 | 1.83 Billion USD | 51.4% |
2020 FY | 6.83 Billion USD | -8.99% |
2019 Q4 | 1.91 Billion USD | 2.41% |
2019 Q2 | 1.9 Billion USD | 4.33% |
2019 Q1 | 1.82 Billion USD | -4.7% |
2019 FY | 7.5 Billion USD | 4.96% |
2019 Q3 | 1.86 Billion USD | -1.84% |
2018 Q2 | 1.82 Billion USD | 1.11% |
2018 FY | 7.15 Billion USD | 5.32% |
2018 Q4 | 1.91 Billion USD | 8.63% |
2018 Q3 | 1.76 Billion USD | -3.19% |
2018 Q1 | 1.8 Billion USD | 2.21% |
2017 Q4 | 1.76 Billion USD | 0.0% |
2017 FY | 6.79 Billion USD | 2.97% |
2016 FY | 6.59 Billion USD | 1.2% |
2015 FY | 6.51 Billion USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
AptarGroup, Inc. | 3.48 Billion USD | -189.379% |
Baxter International Inc. | 14.81 Billion USD | 31.871% |
Becton, Dickinson and Company | 20.17 Billion USD | 49.985% |
Bausch + Lomb Corporation | 4.14 Billion USD | -143.414% |
Haemonetics Corporation | 1.3 Billion USD | -670.933% |
Envista Holdings Corp | 2.56 Billion USD | -293.218% |
ResMed Inc. | 4.68 Billion USD | -115.396% |
Teleflex Incorporated | 2.97 Billion USD | -239.283% |
Warby Parker Inc. | 669.76 Million USD | -1406.787% |
West Pharmaceutical Services, Inc. | 2.94 Billion USD | -242.123% |